ESSO Course on Peritoneal Surface Malignancy

ESSO Course on Peritoneal
Surface Malignancy
In partnership with The Christie School of Oncology
08- 09 O c t o b e r
2015
MANCHESTER (UK)
ESSO Course on Peritoneal
Surface Malignancy
Chair:
Sarah O’Dwyer,The Christie NHS Foundation Trust, Manchester, UK
Co-Chair:
Santiago González-Moreno, MD Anderson Cancer Center,
Madrid, SP
Faculty Members
Thomas Bacheitner- Hofmann, Medical University of Vienna, AT
Norman Carr, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
Charles Honoré, Institut de Cancérologie Gustave Roussy, Villejuif, FR
Brendan Moran, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Pompiliu Piso, St. John of God Hospital, Regensburg, DE
Beate Rau,Charité Campus Mitte, Berlin, DE
Josefin Segelman, Karolinska Institut, Solna, Stockholm, SE
Paul H Sugarbaker, Washington Cancer Center, Washington, USA
Kurt Van der Speeten, Ziekenhuis Oost-Limburg, Genk, BE
Vic Verwaal, The Netherlands Cancer Institute, Amsterdam, NL
Willemien van Driel, Netherlands Cancer Institute, Amsterdam, NL
Local Faculty
Omar Aziz
Rahul Deshpande
Paul Fulford
Vidya Kasipandian
Rohit Kochhar
Andrew Renehan
Mark Saunders
Chelliah Selvasekar
Malcolm Wilson
Aim of the course
A comprehensive workshop on Peritoneal Surface Malignancies
addressing current treatments for specific tumour groups and future
challenges for developing services in different health care settings.
The course will focus on delivering evidence-based clinical practice
and achieving quality assured outcomes for patients undergoing
abdominal and pelvic cytoreductive surgery and intraperitoneal
chemotherapy.
Topics covered
• Neoplasia of the appendix: pathology, diagnosis and clinical
pathways
• Peritoneal Surface Malignancies: outcomes for colorectal,
ovarian, gastric cancers and mesothelioma
• Surgical techniques: tips and tricks to achieve complete
cytoreduction
• Intraperitoneal chemotherapy: why, what, who and how
• Setting up a service: challenges and opportunities
Ideal Course candidates
• Consultant Surgeons/gynaecologists/oncologists
• Senior residents/fellows surgery/gynaecology/oncology
• Senior Nurse Practitioners in PSM/oncology
Educational methods
• Live surgical session with interactive discussion
• Video sessions/workshops on surgical technique and HIPEC
• Plenary lectures
• MDT case management
• Interactive voting on key topics
Course Venue
The Christie NHS Foundation Trust
Wilmslow Road
Manchester, M20 4BX
United Kingdom
Course coordination
Ana Galán
European Society of Surgical Oncology (ESSO)
Email. [email protected]
Application Procedure
Please go to www.essoweb.org (education/projects & courses) to
complete your application and apply for the course.
Participation fee
The participation fee is 650 € for ESSO members and 800€ for
non-members. It includes registration for the 2-day course,coffee
breaks and lunches and a social dinner.
Accreditation
An application for accreditation has been submitted to the European
Accreditation Council for CME (EACCME) of the European Union
of Medical Specialists (UEMS).
Programme
Thursday 08 October
08:15-08:30 Welcome
Aims and objectives; global guidelines
S. O’Dwyer, S. González-Moreno
Generic challenges in PSM
Service delivery for PSM
Moderators: B. Moran, P. Piso
08:30-08:45
The European picture: reference centres and networks
08:45-09:00
Setting up a service: challenges and opportunities
T. Bacheitner - Hofman
09:00-09:05
Discussion
09:05-09:35
Imaging for PSM: what the MDT should look for
09:35-09:40
Discussion
S. González-Moreno
R. Kochar
09:40-10:10
Keynote address:
Evidence base and principles of management of peritoneal
metastases
P. Sugarbaker
Chemotherapy
Moderators: A. Renehan, V. Verwaal
10:10-10:25
HIPEC: overview of current regimes
10:25-10:30
Can we reach a consensus: voting
10:30-10:40
Systemic chemotherapy: when how and what
10:40-10:50
EPIC: when how and what
10:50-10:55
Can we reach a consensus: voting
10:55-11:15
Coffee break
Perioperative support: tips and tricks
11:15-11:30
Anaesthesia, critical care and pain management
11:30-11:45
Nutrition and enhanced recovery
11:45-12:00
Complications : how to avoid them
12:00-12:15
Standardised recording of morbidity and mortality
K. Van der Speeten
M. Saunders
K. Van der Speeten
Moderators: P. Fulford, T.B- Hofmann
V. Kasipandian
O. Aziz
B. Rau
A. Reneham
12:15-12:30
Recommendations for follow up: why, who and for
how long?
12:30-12:45
Discussion/voting
T. Cecil
12.45-13.30Lunch
Surgical techniques: tips and tricks
13:30-14:30
•
•
•
•
•
•
14:30-14:45
Discussion
14:45-15:00
Coffee break
15:00-17:00
Parallel sessions
Surgical techniques workshops/videos
MDT case discussions
Pathology workshop
Nursing workshop
Moderators: M. Wilson, S.G. Moreno
RUQ, R. Deshpande
LUQ, P. Piso
Central abdomen, M. Deraco
Pelvis, T. Cecil
MAS, C. Selvaseker
HIPEC, K. Van der Speeten
Friday 09 October
Disease specific challenges in PSM
Appendix neoplasia
08:30-08:55
Keynote address:
Concensus on the classification of appendix neoplasia
08:55-09:00
Discussion
09:00-09:15
PMP Presentation and outcomes
09:15-09:30
Management of recurrence
09:30-09:40
Discussion
09:40-10:15
Surgery
10.15-10.45 Coffee break
Moderators: P. Fulford, M. Deraco
N. Carr
M. Wilson
B.Moran
Moderators: S. O’ Dwyer, C. Selvaseker, A. Renehan, P. Fulford
Case Presentation and Live Surgery
Colon and rectum
10:45-11:00
Patient selection and outcomes
11:00-11:10
Selecting high risk patients
11:10-11:25
Future opportunities for CRS in colorectal cancer
11:25-11:30
Discussion
11:30-12:00
Surgery
Live surgery/ case discusion
Moderator: P. Piso
C. Honore
J. Segelman
P.Sugarbaker
Mesothelioma
Moderator: T. Cecil
12:00-12:40
Keynote address:
Current and Future directions for the treatment of Peritoneal Mesothelioma
M. Deraco
12:40-12:45
Discussion
12:45-13:45Lunch (live surgery continues during lunch break)
13:45-14:10
Gastric Cancer
14:10-14:15
Discussion
14:15-14:30
Surgery
Live surgery
14:30-15:00
Ovarian Cancer
Moderator: C. Honore
Patient selection outcomes and future potential
P. Piso
Moderator: V. Verwaal
Keynote adress:
Evidence base and recommendations for the treatment of ovarian peritoneal metastasis
W. van Driel
15.00-15.05Discussion
15:05-15:20
Palliative treatment for PSM
15:20-15:25
Discussion
Moderator: B.Rau
Strategies and outcomes from palliation
K. Van der Speeten
15:25-15:50
MDT Case discussions/Live surgery update
15:50-16:00
Summary and Close
ESSO is grateful for the continuous support of
its corporate sponsors
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83
B 1200 Brussels
Tel: +32 (0)2 5373106
Fax : +32 (0) 5390374
Email : [email protected]
Website : www.essoweb.org